Dianthus Therapeutics Stock Forecast - 4 Period Moving Average
| DNTH Stock | 23.60 0.24 1.03% |
The 4 Period Moving Average forecasted value of Dianthus Therapeutics on the next trading day is expected to be 24.01 with a mean absolute deviation of 0.84 and the sum of the absolute errors of 48.04. Dianthus Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Dianthus Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Dianthus |
Dianthus Therapeutics 4 Period Moving Average Price Forecast For the 20th of November
Given 90 days horizon, the 4 Period Moving Average forecasted value of Dianthus Therapeutics on the next trading day is expected to be 24.01 with a mean absolute deviation of 0.84, mean absolute percentage error of 1.25, and the sum of the absolute errors of 48.04.Please note that although there have been many attempts to predict Dianthus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Dianthus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Dianthus Therapeutics Stock Forecast Pattern
| Backtest Dianthus Therapeutics | Dianthus Therapeutics Price Prediction | Buy or Sell Advice |
Dianthus Therapeutics Forecasted Value
In the context of forecasting Dianthus Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Dianthus Therapeutics' downside and upside margins for the forecasting period are 20.43 and 27.59, respectively. We have considered Dianthus Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Dianthus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Dianthus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.9854 |
| Bias | Arithmetic mean of the errors | 0.2188 |
| MAD | Mean absolute deviation | 0.8428 |
| MAPE | Mean absolute percentage error | 0.0316 |
| SAE | Sum of the absolute errors | 48.04 |
Predictive Modules for Dianthus Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dianthus Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dianthus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Dianthus Therapeutics
For every potential investor in Dianthus, whether a beginner or expert, Dianthus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dianthus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dianthus. Basic forecasting techniques help filter out the noise by identifying Dianthus Therapeutics' price trends.Dianthus Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dianthus Therapeutics stock to make a market-neutral strategy. Peer analysis of Dianthus Therapeutics could also be used in its relative valuation, which is a method of valuing Dianthus Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dianthus Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Dianthus Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Dianthus Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Dianthus Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Dianthus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dianthus Therapeutics shares will generate the highest return on investment. By undertsting and applying Dianthus Therapeutics stock market strength indicators, traders can identify Dianthus Therapeutics entry and exit signals to maximize returns.
Dianthus Therapeutics Risk Indicators
The analysis of Dianthus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dianthus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dianthus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.6 | |||
| Standard Deviation | 3.5 | |||
| Variance | 12.28 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| 300825 | Iat Automobile Technology | |
| 600666 | Aurora Optoelectronics Co | |
| 000678 | Xiangyang Automobile Bearing | |
| 603818 | Qumei Furniture Group | |
| 002156 | TongFu Microelectronics Co |
Check out Historical Fundamental Analysis of Dianthus Therapeutics to cross-verify your projections. For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dianthus Therapeutics. If investors know Dianthus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dianthus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 7.22 | Revenue Per Share 0.19 | Quarterly Revenue Growth 1.351 | Return On Assets (0.19) | Return On Equity (0.26) |
The market value of Dianthus Therapeutics is measured differently than its book value, which is the value of Dianthus that is recorded on the company's balance sheet. Investors also form their own opinion of Dianthus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dianthus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dianthus Therapeutics' market value can be influenced by many factors that don't directly affect Dianthus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dianthus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dianthus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dianthus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.